Doxa AB (publ) DOXA.ST
DOXA.ST
Doxa AB (publ) FLUO.ST
FluoGuide A/S ADDV-B.ST
ADDvise Group AB (publ) BACTI-B.ST
Bactiguard Holding AB (publ) CANTA.ST
Cantargia AB (publ) QLINEA.ST
Q-linea AB (publ) ENZY.ST
Enzymatica AB (publ) CLBIO.ST
Corline Biomedical AB IBT-B.ST
Infant Bacterial Therapeutics AB (publ) MOB.ST
Moberg Pharma AB (publ)
Doxa AB (publ) FLUO.ST
FluoGuide A/S ADDV-B.ST
ADDvise Group AB (publ) BACTI-B.ST
Bactiguard Holding AB (publ) CANTA.ST
Cantargia AB (publ) QLINEA.ST
Q-linea AB (publ) ENZY.ST
Enzymatica AB (publ) CLBIO.ST
Corline Biomedical AB IBT-B.ST
Infant Bacterial Therapeutics AB (publ) MOB.ST
Moberg Pharma AB (publ)
Performance
| Periode | DOXA.ST | FLUO.ST | ADDV-B.ST | BACTI-B.ST | CANTA.ST | QLINEA.ST | ENZY.ST | CLBIO.ST | IBT-B.ST | MOB.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 56.97 % | 5.05 % | -20.61 % | -47.41 % | 46.32 % | -33.00 % | -44.00 % | 124.73 % | 13.35 % | 0.86 % |
| YTD | -23.03 % | 1.96 % | -71.44 % | -56.08 % | 40.29 % | -96.45 % | 19.51 % | 118.62 % | 5.05 % | -19.57 % |
| 1Y | -51.13 % | 8.62 % | -80.00 % | -61.76 % | -22.56 % | -98.98 % | 10.73 % | 160.60 % | 61.23 % | -31.89 % |
| 3Y | -89.49 % | -24.36 % | -80.84 % | -84.49 % | -36.57 % | -99.96 % | -39.13 % | 145.31 % | 5.79 % | -43.97 % |
| 5Y | -51.59 % | -20.61 % | -6.43 % | -88.79 % | -95.74 % | -99.98 % | -90.23 % | 23.88 % | -56.68 % | -87.28 % |
| 10Y | -50.67 % | 766.67 % | -63.67 % | 64.14 % | -70.61 % | -99.96 % | -47.17 % | 85.27 % | 3.14 % | -97.39 % |
| From the beginning | -78.05 % | 766.67 % | -65.73 % | -48.41 % | -71.91 % | -99.96 % | -65.85 % | 106.06 % | 3.14 % | -94.99 % |